Pavlovskyi S. A., Vozniuk O. R.

QUALITY OF LIFE OF PATIENTS AFTER SUFFERING FROM CORONA VIRUS DISEASE (COVID-19)

---

Show/Download

About the author:

Pavlovskyi S. A., Vozniuk O. R.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

The article deals with patients' quality of life (QOL) after coronavirus disease (COVID-19). The study examined 20 patients aged 56.17±1.24 years, one month after inpatient treatment for COVID-19. The QOL of patients was studied using the Medical Outcomes Study Short Form 36 (SF-36) at the time of the visit to the family doctor and with a retrospective assessment at the time of hospitalisation. One month after treatment, patients complained of fatigue and breathing problems, shortness of breath, cough, sleep disturbances and dizziness, and hair loss. They were much less concerned about arrhythmia and memory disorders, intestinal disorders, muscle pain and tinnitus, and lower limb vascular thrombosis. During a visit to a family doctor, a decrease in role functioning (by 12.74%) and physical functioning (by 4.04%), mental health (by 9.57%) and vitality (by 3.72%) were identified, while assessments of general health (by 4.42%) and pain (by 1.82%) increased, which we believe is due to concerns about the failure to provide care at the outpatient stage of treatment in case of new complications. Physical functioning was poorly assessed by 80% of patients, role-based physical functioning by 85%, vitality by 60%, social activity by 70%, and emotional functioning by 60%. The study of QOL of patients after COVID-19 is necessary to identify the causes that affect it and to develop effective treatment measures that will prevent the occurrence of complications.

Tags:

Bibliography:

1. European Centre for Disease Prevention and Control (ECDC). Country overview report: week 34 2023. Stockholm: ECDC; 2023. Available from: https://covid19-country-overviews.ecdc.europa.eu/index.html.
2. European Centre for Disease Prevention and Control. Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023. Solna: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/newsevents/epidemiological-update-covid-19-transmission-eueea-sars-cov-2-variants-and-public.
3. Tarazona V, Kirouchena D, Clerc P, Pinsard-Laventure F, Bourrion B. Quality of Life in COVID-19 Outpatients: A Long-Term Follow-Up Study. J. Clin. Med. 2022;11(21):6478. DOI: 10.3390/jcm11216478.
4. Kintrilis N, Kontaxakis A, Papalamidous A, Manthos P, Simeonidou Z, StavrianouA, et al. Quality of life after coronarovirus disease 2019 Hospitalization and rehabilitation needs. J Rehabil Med Clin Commun. 2023;6:5327. DOI: 10.2340/jrmcc.v6.5327.
5. Bull-Otterson L. Post-COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years. United States, March 2020–November 2021. Morbidity and Mortality Weekly Report. 2022;71(21):713-717. DOI: 10.15585/mmwr.mm7121e1.
6. Taquet M, Geddes J, Husain M, Luciano S, Harrison P. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2022;8(5):416-427. DOI: 10.1016/S2215-0366(21)00084-5.
7. Lemhöfer C, Sturm C, Loudovici-Krug D, Guntenbrunner C, Bülow M, Reuken P, et al. Quality of life and ability to work of patients with Post-Covid syndrome in relation to the number of existing symptoms and the duration since infection up to 12 months: a cross-sectional study. Qual Life Res. 2023;32(7):1991-2002. Available from: https://link.springer.com/article/10. 1007/s11136-023-03369-2.
8. Di Maria E, Latini A, Borgiani P, Novelli G. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): Rapid systematic review and field synopsis. Human Genomics. 2020;14(1):30. DOI: 10.1186/s40246-020-00280-6.
9. Groff D, Sun A, Ssentongo A, Ba D, Parsons N, Poudel G, et al. Short-term and long-term rates of Postacute Sequelae of SARS-CoV-2 Infection: A systematic review. JAMA Network Open. 2021;4(10):e2128568. DOI: 10.1001/jamanetworkopen.2021.28568.
10. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE; 2020. Available from: https://www.nice.org.uk/guidance/ng188/resources/ covid19-rapid-guideline-managing-the-longterm-effectsof-covid19-pdf-51035515742.
11. Raveendran A, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes & metabolic syndrome. 2021;15(3):869-875. DOI: 10.1016/j.dsx.2021.04.007.
12. Lemhöfer C, Best N, Bökel A, Brugger S, Gutenbrunner C, Loudovici-Krug D, et al. Zufriedenheit COVID-19-Erkrankter mit den Akteuren des Gesundheitssystems und der rehabilitativen Therapieversorgung unter Verwendung des COVID-19-Rehabilitation Needs Questionnaire (C19-RehabNeQ) in Bayern. Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin. 2022;32(01):11-18. DOI: 10.1055/a1528-1667.
13. Lemhöfe C, Gutenbrunner C, Schiller J, Loudovici-Krug D, Best N, Bökel A, et al. Assessment of rehabilitation needs in patients after COVID-19: Development of the COVID-19-rehabilitation needs survey. J Rehabil Med. 2021;53(4):jrm00183. DOI: 10.2340/16501977-2818.
14. Lemhöfer C, Best N, Gutenbruner C, Loudovici-Krug D, Teixido L, Sturm C. Perceived and real work capacity of patients with post-COVID symptoms after mild acute course: A Analysis of the Rehabilitation Needs Questionnaire (RehabNeQ). Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin. 2022;32(03):151-158. DOI: 10.1055/a-1674-8044.
15. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J. Infect. Public Health. 2020;13(5):667-673. DOI: 10.1016/j.jiph.2020.03.019.
16. MOZ Ukrayiny. Nakaz MOZ Ukrayiny № 762 vid 02 kvitnya 2020 roku (u redaktsiyi Nakazu MOZ Ukrayiny vid 22 lyutoho 2022 roku № 358) «Protokol nadannya medychnoyi dopomohy dlya likuvannya koronarovirusnoyi khvoroby (COVID-19). Kyyiv: MOZ Ukrayiny; 2022. Dostupno: https://www.dec.gov.ua/wp-content/uploads/2022/02/2020_762_ nakaz_covid19.pdf. [in Ukrainian].
17. Derzhavnyy ekspertnyy tsentr MOZ Ukrayiny. Klinichna nastanova «Klinichne vedennya patsiyentiv z COVID-19. Kyyiv: Derzhavnyy ekspertnyy tsentr MOZ Ukrayiny. Dostupno: https://www.dec.gov.ua/wp-content/uploads/2021/12/2021_. [in Ukrainian].
18. MOZ Ukrayiny. Nakaz Ministerstva okhorony zdorovʺya Ukrayiny vid 20.04.2021 № 771 «Protokol nadannya reabilitatsiynoyi dopomohy patsiyentam z rekonvalestsentnoyu khvoroboyu (COVID-19) ta rekonvalestsentam». Kyyiv: MOZ Ukrayiny; 2021. Dostupno: . [in Ukrainian].
19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513. DOI: 10.1016/S0140-6736(20)30211-7.
20. MOZ Ukrayiny. Nakaz Ministerstva okhorony zdorov’ya Ukrayiny «Pro zatverdzhennya form pervynnoyi oblikovoyi dokumentatsiyi ta Instruktsiy shchodo yikh zapovnennya, shcho vykorystovuyutʹsya u zakladakh okhorony zdorov’ya nezalezhno vid formy vlasnosti ta pidporyadkuvannya» vid 14 lyutoho 2012 roku № 110. Kyyiv: MOZ Ukrayiny; 2012. Dostupno: http://search.ligazakon.ua/l_doc2.nsf/link1/ RE20974Z.html. [in Ukrainian].
21. VMA. Khel’sinskaya deklaratsiya vsemirnoy meditsinskoy assotsiatsii. Eticheskiye printsipy meditsinskikh issledovaniy s uchastiyem cheloveka v kachestve ob”yekta issledovaniya. 2008. Dostupno: http://www.mniip. org/science/library/Helsinki_declaration.php.
22. MOZ Ukrayiny. Nakaz MOZ № 762 Ukrayiny Pro zatverdzhennya protokolu «Nadannya medychnoyi dopomohy dlya likuvannya koronavirusnoyi khvoroby (COVID-19)». Kyyiv: MOZ Ukrayiny; 2020. Dostupno: https://www.dec.gov.ua/wp-content/uploads/2022/02/2020_762_ nakaz_ covid19.pdf. [in Ukrainian].
23. Patel A, Donegan D, Albert T. The 36-item short form. J Am Acad Orthop Surg. 2007 Feb;15(2):126-34. DOI: 10.5435/00124635-200702000-00007.
24. Babak V, Biletskiy A, Pristavka O, Pristavka P. Statistychna obrobka danih. K.: MIVVTS; 2001. 387 s.
25. Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. Journal of Medical Virology. 2022;94:253-262. DOI: 10.1002/jmv.27309.
26. Meys R, Delbressine J, Goërtz Y, Vaes A, Machado F, van Herck M, et al. Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J. Clin. Med. 2020;9(12):3993. DOI: 10.3390/jcm9123993.
27. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry. 2020;7(7):611-627. DOI: 10.1016/S2215-0366(20)30203-0.
28. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic – BRS Consensus Guidelines. Clinical Otolaryngology. 2021;46(1):16-22. DOI: 10.1111/coa.13636.
29. Lukashchuk S, Lemko O. Otsinka yakosti zhyttya khvorykh pislya Covid-19 pid vplyvom vidnovlyuvalʹnoho likuvannya za danymy opytuvalʹnyka EQ-5D-5L Zbirnyk naukovykh pratsʹ SCIENTIA. 2021. Dostupno: . [in Ukrainian].

Publication of the article:

«Bulletin of problems biology and medicine», 2024 Issue 1, 172, 232-238 pages, index UDC 578.834:616.988.7-036.1:616.151.5-002-092-07

DOI:

10.29254/2077-4214-2024-1-172-232-238